TP53 and cancer: The major mechanisms include response to hypoxia, turnover of antioxidant enzymes, oxidative damage-induced protein aggregation of regulatory molecules like TGF-β1, p53, enhanced survival in RAS-mutated cancers, EMT transition, and drug resistance.